NYSE:PFEPfizer Stock Price, Forecast & News

Pfizer's stock was trading at $32.17 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PFE stock has increased by 4.9% and is now trading at $33.74. View which stocks have been most impacted by Coronavirus.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pfizer in the last year. There are currently 8 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Pfizer.

Pfizer is scheduled to release its next quarterly earnings announcement on Tuesday, July 28th 2020. View our earnings forecast for Pfizer.

Pfizer will be holding an earnings conference call on Tuesday, July 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Pfizer Inc. (NYSE:PFE) released its quarterly earnings data on Tuesday, April, 28th. The biopharmaceutical company reported $0.80 EPS for the quarter, beating the Zacks' consensus estimate of $0.71 by $0.09. The biopharmaceutical company had revenue of $12.03 billion for the quarter, compared to the consensus estimate of $11.38 billion. Pfizer had a return on equity of 25.76% and a net margin of 31.17%. The company's revenue was down 8.3% compared to the same quarter last year. During the same period in the prior year, the business earned $0.85 earnings per share. View Pfizer's earnings history.

Pfizer declared a quarterly dividend on Thursday, June 25th. Shareholders of record on Friday, July 31st will be paid a dividend of $0.38 per share on Tuesday, September 1st. This represents a $1.52 annualized dividend and a dividend yield of 4.51%. The ex-dividend date is Thursday, July 30th. View Pfizer's dividend history.

Pfizer declared that its Board of Directors has approved a stock buyback program on Friday, December 14th 2018, which permits the company to repurchase $10,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to purchase up to 3.8% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company's board of directors believes its shares are undervalued.

Pfizer issued an update on its FY20 earnings guidance on Tuesday, April, 28th. The company provided earnings per share (EPS) guidance of $2.82-2.92 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.70. The company issued revenue guidance of $48.5-50.5 billion, compared to the consensus revenue estimate of $47.01 billion.

12 equities research analysts have issued 1 year target prices for Pfizer's shares. Their forecasts range from $24.00 to $53.00. On average, they expect Pfizer's share price to reach $38.61 in the next year. This suggests a possible upside of 14.4% from the stock's current price. View analysts' price targets for Pfizer.

Media stories about PFE stock have trended negative recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Pfizer earned a daily sentiment score of -2.1 on InfoTrie's scale. They also assigned news coverage about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news about Pfizer.

Some companies that are related to Pfizer include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Eli Lilly And Co (LLY), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), Horizon Therapeutics (HZNP), Mylan (MYL), Perrigo (PRGO), Jazz Pharmaceuticals (JAZZ), Nektar Therapeutics (NKTR), Pacira Biosciences (PCRX), Corcept Therapeutics (CORT) and Zogenix (ZGNX). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Pfizer investors own include AT&T (T), Cisco Systems (CSCO), Johnson & Johnson (JNJ), Verizon Communications (VZ), Intel (INTC), AbbVie (ABBV), General Electric (GE), Walt Disney (DIS), Bank of America (BAC) and Exxon Mobil (XOM).

Pfizer trades on the New York Stock Exchange (NYSE) under the ticker symbol "PFE."

Pfizer's stock is owned by many different retail and institutional investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.08%), DNB Asset Management AS (0.08%), Confluence Investment Management LLC (0.04%), State of Alaska Department of Revenue (0.02%), Nexus Investment Management ULC (0.01%) and Park National Corp OH (0.01%). Company insiders that own Pfizer stock include Alexander R Mackenzie, Dawn Rogers, Douglas M Lankler, Frank A Damelio, Ian C Read, Jennifer B Damico, Kirsten Lund-Jurgensen, Laurie J Olson, Loretta V Cangialosi, Mikael Dolsten, Pfizer Inc, Rady A Johnson, Sally Susman and Scott Gottlieb. View institutional ownership trends for Pfizer.

PFE stock was sold by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., DNB Asset Management AS, HNP Capital LLC, Municipal Employees Retirement System of Michigan, Confluence Investment Management LLC, First National Bank of Mount Dora Trust Investment Services, M&R Capital Management Inc., and American National Bank. Company insiders that have sold Pfizer company stock in the last year include Douglas M Lankler, and Jennifer B Damico. View insider buying and selling activity for Pfizer.

PFE stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Mountain Capital Investment Advisors Inc, Bogart Wealth LLC, Corrado Advisors LLC, Farmers Trust Co., KG&L Capital Management LLC, Modus Advisors LLC, and Trinity Legacy Partners LLC. Company insiders that have bought Pfizer stock in the last two years include Pfizer Inc, and Scott Gottlieb. View insider buying and selling activity for Pfizer.

Shares of PFE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PFE stock can currently be purchased for approximately $33.74.

Pfizer has a market capitalization of $187.42 billion and generates $51.75 billion in revenue each year. The biopharmaceutical company earns $16.27 billion in net income (profit) each year or $2.95 on an earnings per share basis. Pfizer employs 88,300 workers across the globe.

The official website for Pfizer is www.pfizer.com.

Pfizer's mailing address is 235 EAST 42ND STREET, NEW YORK NY, 10017. The biopharmaceutical company can be reached via phone at 212-733-2323.